- Home
- ADAP vs FCO Comparison
ADAP vs FCO Comparison
Compare ADAP & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- FCO
- Stock Information
- Founded
- ADAP 2008
- FCO 1991
- Country
- ADAP United Kingdom
- FCO United Kingdom
- Employees
- ADAP N/A
- FCO N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- ADAP Health Care
- FCO Finance
- Exchange
- ADAP Nasdaq
- FCO Nasdaq
- Market Cap
- ADAP 75.5M
- FCO 78.3M
- IPO Year
- ADAP 2015
- FCO N/A
- Fundamental
- Price
- ADAP $0.29
- FCO $6.24
- Analyst Decision
- ADAP Buy
- FCO
- Analyst Count
- ADAP 6
- FCO 0
- Target Price
- ADAP $1.52
- FCO N/A
- AVG Volume (30 Days)
- ADAP 1.6M
- FCO 100.1K
- Earning Date
- ADAP 05-13-2025
- FCO 01-01-0001
- Dividend Yield
- ADAP N/A
- FCO 14.96%
- EPS Growth
- ADAP N/A
- FCO N/A
- EPS
- ADAP N/A
- FCO 0.43
- Revenue
- ADAP $179,639,000.00
- FCO N/A
- Revenue This Year
- ADAP N/A
- FCO N/A
- Revenue Next Year
- ADAP $52.49
- FCO N/A
- P/E Ratio
- ADAP N/A
- FCO $12.30
- Revenue Growth
- ADAP 878.53
- FCO N/A
- 52 Week Low
- ADAP $0.20
- FCO $4.73
- 52 Week High
- ADAP $1.48
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- ADAP 53.94
- FCO 56.95
- Support Level
- ADAP $0.26
- FCO $6.14
- Resistance Level
- ADAP $0.30
- FCO $6.40
- Average True Range (ATR)
- ADAP 0.03
- FCO 0.13
- MACD
- ADAP 0.00
- FCO -0.01
- Stochastic Oscillator
- ADAP 58.12
- FCO 42.86
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.